Skip to main content
AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
66.11
-0.48 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
66.11
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

AnaptysBio Revenue

In the year 2025, AnaptysBio had annual revenue of $234.60M with 157.01% growth. AnaptysBio had revenue of $108.25M in the quarter ending December 31, 2025, with 151.08% growth.

Revenue (ttm)
$234.60M
Revenue Growth
+157.01%
P/S Ratio
8.20
Revenue / Employee
$2,255,798
Employees
104
Market Cap
1.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025234.60M143.32M157.01%
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Vericel 276.26M
Stoke Therapeutics 184.42M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Taysha Gene Therapies 9.77M
Inhibrx Biosciences 1.30M
Revenue Rankings

ANAB News

More News